Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year to $675 a month, the Danish…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/novo-nordisk-slash-us-list-prices-ozempic-and-wegovy-wsj-2026a10005sl?src=rss
Author :
Publish date : 2026-02-24 12:42:00
Copyright for syndicated content belongs to the linked Source.
